Two Oklahoma hospitals held off spread of ‘superbug’

Both incidents reflect the growing problem of multidrug-resistant Candida auris


Teams of health officials at two Oklahoma health facilities contained the spread of a fungal “superbug” that federal officials have declared a serious global health threat, according to an article on the Oklahoma Watch website.

Both incidents occurred in the last few years and reflect the growing problem of multidrug-resistant Candida auris.

In April of 2017, experts from the Centers for Disease Control and Prevention (CDC) came to the University of Oklahoma Medical Center in Oklahoma City after a patient tested positive for the drug-resistant fungus. About a year later, a patient at a southeast Oklahoma health facility tested positive C. auris, during a routine test. 

In both cases, health officials isolated the patients, locked down their rooms. 

Read the article.



April 30, 2019


Topic Area: Infection Control


Recent Posts

CMMS, Data and the Path to Compliance

Taking control of healthcare facilities data in CMMS enables managers to use it to ensure the efficient operation and maintenance of their assets.


Healthcare is a Major Ransomware Target

Healthcare is the third-most-targeted sector, according to the report.


Woodland Recovery Center to Expand with New Facility in Mississippi

The new 100-bed facility is expected to be completed in 2026.


How to Design Senior Care Facilities for Veterans

Designing for veterans requires a specific set of needs.


Allegheny Health Network Struck by Third-Party Vendor Data Breach

The organization is not aware of any actual or attempted identity theft or fraud as a result of this incident.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.